Are Aortic Stenosis and Kidney Dysfunction Associated?

Courtesy of Dr. Carlos Fava.

Aortic stenosis happens in 2.8% of patients over 75, and is even more frequent in dialysis patients. However, it remains unclear whether kidney dysfunction increases the risk of aortic stenosis.

The present study looked at 1,121,875 patients from the SCREAM project (Stockholm CREAtinine Measurements).

 

Mean age was 50, and 54% of the population were women. 16.2% of patients suffered from hypertension, hyperlipidemia 9.9%, diabetes 5.5%, ischemic cardiomyopathy 5.3% and stroke 3%. Estimated glomerular filtration rate (eGFR) was 96 ml/min/1.73 m2 (IQR: 82 to 109 ml/min/1.73 m2).


Read also: Outcomes of Contemporary DES in Patients with Diabetes: Do They Render Freedom Obsolete?


Patients were divided according to GFR: 699,957 presented >90 eGFR, ml/min/1.73 m2; 354,969 between 60-90; 44,744 between 45-59; 16,611 between 30-44; and 5,594 <30.

 

Patients presenting the lowest eGFR were mostly women, had more comorbidities and required more medication.

 

Follow up was at 5.1 years. 5,858 patients developed aortic stenosis, that is, there was an incidence of 1.13 every 1000 person/year. Patients presenting eGFR >90 ml/min/1.73 m2 were 0.34 every 1000 person/year, increasing as eGFR decreased, reaching 8.27 in those presenting eGFR <30 ml/min/1.73 m2.


Read also: The Price of Binge Watching: Subclinical Atherosclerosis and Sleep Quality.


Patients with eGFR ≤44 ml/min/1.73 m2 presented approximately 20% higher risk of developing aortic stenosis, even excluding those that had had events or cardiac failure.

 

Conclusion

Moderate to severe chronic kidney dysfunction is associated to increased risk of aortic stenosis.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Kidney Dysfunction and the Risk of Developing Aortic Stenosis.

Reference: Georgios Vavilis, et al. J Am Coll Cardiol 2019;73:305–14.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...